We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test as Accurate as Lumbar Punctures for Detecting Alzheimer’s

By LabMedica International staff writers
Posted on 25 Jan 2024

Individuals with Alzheimer’s disease often exhibit accumulations of amyloid and tau proteins in their brains, key indicators of the condition. More...

Typically, Alzheimer’s diagnosis is based on symptoms like cognitive and memory issues. However, only a small percentage (2%) of those diagnosed with dementia undergo ‘gold standard’ diagnostic methods such as PET scans or lumbar punctures. With the advent of novel Alzheimer’s therapies, enhancing diagnostic accuracy has become increasingly crucial. Now, findings from a study indicate that a commercial blood test might be able to identify Alzheimer’s disease as effectively as standard lumbar punctures. This test specifically detects ‘p-tau217’, a variant of the tau protein, which is a primary marker of Alzheimer’s.

This new study led by researchers at the University of Gothenburg (Mölndal, Sweden) demonstrated that blood levels of p-tau217 correlate with the levels of amyloid and tau proteins identified in brain scans and lumbar punctures. This discovery holds significant promise for transforming the diagnostic process for suspected Alzheimer’s patients. Notably, the study utilized a threshold for categorizing individuals into those likely or unlikely to have Alzheimer’s, and an intermediate group requiring further assessment through conventional methods like lumbar punctures or PET scans. By applying this blood test approach, researchers anticipate a substantial reduction, by approximately 80%, in the need for these more invasive follow-up tests.

However, several questions remain unresolved. There is a need for a more comprehensive understanding of how these blood tests perform in everyday clinical settings, particularly among diverse patient groups. Additionally, like new medical treatments, these blood tests must undergo regulatory approval before they can be integrated into healthcare practice. People need a quick and accurate diagnosis, which will “ultimately bring us closer towards a cure for dementia” said Dr. Sheona Scales, Director of Research at Alzheimer’s Research UK. “In the past year, we have seen incredible progress in the development of blood-based Alzheimer’s tests. And as we see more and more different types of tests becoming available, studies like this are key to understanding which are most accurate.”

Related Links:
University of Gothenburg


New
Gold Member
Hybrid Pipette
SWITCH
Collection and Transport System
PurSafe Plus®
8-Channel Pipette
SAPPHIRE 20–300 µL
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: Automated cell imaging discriminates CD8+ T cells according to natalizumab treatment outcome in MS patients (B Chaves et al., Nat Commun 16, 5533 (2025). DOI: 10.1038/s41467-025-60224-3)

Novel Tool Predicts Most Effective Multiple Sclerosis Medication for Patients

Multiple sclerosis (MS) is a chronic autoimmune and degenerative neurological disease that affects the central nervous system, leading to motor, cognitive, and mental impairments. Symptoms can include... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: ELITechGroup’s unique Real-Time PCR technologies include the revolutionary Minor Groove Binder (Photo courtesy of ELITechGroup)

ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases

Molecular testing has become central to diagnosing and monitoring infectious diseases by analyzing genetic information. The use of PCR during the COVID-19 pandemic showed its value, but traditional systems... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.